• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 485199 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1416874296 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1416874296 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Watch for Continued Gains in Shares of Acorda Therapeutics (ACOR)

Published on Tue, 04/23/2013 - 14:12
By Adrienne Chilton

Shares of Acorda Therapeutics (NASDAQ:ACOR) traded at a new 52-week high today of $40.87. This new high was reached on below average trading volume as 295,000 shares traded hands, while the average 30-day volume is approximately 461,000 shares.

Acorda Therapeutics Inc. is a biotechnology company that is developing therapies for spinal cord injury and related neurological conditions, including multiple sclerosis. Additionally, Acorda is developing multiple approaches to regeneration and repair of the spinal cord and brain.

Over the past year, Acorda Therapeutics has traded in a range of $21.04 to $40.87 and is now at $39.70, 89% above that low. Over the last five market days, the 200-day moving average (MA) has gone up 0.9% while the 50-day MA has advanced 2.1%.

Acorda Therapeutics (NASDAQ:ACOR) is currently priced 19.0% above its average consensus analyst price target of $32.14. The stock should discover initial support at its 50-day moving average (MA) of $31.57 and subsequent support at its 200-day MA of $26.74.

By Adrienne Chilton
achilton@fnno.com

Latest News from FNNO

Shares of Weyerhaeuser Rise Above Previo...

Shares of Weyerhaeuser (NYSE:WY) traded at a new 52-week high today of $34.76. Approxi ...

Watch for Continued Gains in Shares of V...

Shares of VCA Antech (NASDAQ:WOOF) traded today at $47.00, breaking its 52-week high. ...

Recent 52-Week High Exceeded in Shares o...

Wells Fargo (NYSE:WFC) traded today at a new 52-week high of $54.36. Approximately 6.7 ...

Watch for Continued Gains in Shares of W...

Wabtec (NYSE:WAB) traded at a new 52-week high today of $91.14. So far today approxima ...

Ventas: 52-Week High Recently Eclipsed (...

Shares of Ventas (NYSE:VTR) traded today at $69.92, breaking its 52-week high. This ne ...

Recent 52-Week High Exceeded in Shares o...

Validus Holdings (NYSE:VR) traded today at a new 52-week high of $41.40. This new high ...

US Bancorp Looks to Continue to Trade Ab...

US Bancorp (NYSE:USB) traded today at a new 52-week high of $44.49. Approximately 3.2 ...

Union Pacific Looks to Continue to Trade...

Shares of Union Pacific (NYSE:UNP) traded at a new 52-week high today of $123.37. Appr ...